Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients

In Japan, cetuximab with concurrent bioradiotherapy (BRT) for squamous cell carcinoma of head and neck (SCCHN) was approved in December 2012. We herein report our initial experience of BRT, with special emphasis on acute toxicities of this combination therapy. Thirty-one non-metastatic SCCHN patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurokawa, Marie, Watanabe Nemoto, Miho, Harada, Rintaro, Kobayashi, Hiroki, Horikoshi, Takuro, Kanazawa, Aki, Togasaki, Gentaro, Abe, Yukinao, Chazono, Hideaki, Hanazawa, Toyoyuki, Okamoto, Yoshitaka, Uno, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577007/
https://www.ncbi.nlm.nih.gov/pubmed/26160181
http://dx.doi.org/10.1093/jrr/rrv038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577007/
https://www.ncbi.nlm.nih.gov/pubmed/26160181
http://dx.doi.org/10.1093/jrr/rrv038

Ejemplares similares